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Abstract
Apoptosis of hepatic stellate cells (HSC) has previously been shown to occur during spontaneous
resolution of experimental liver fibrosis. TIMP-1 has also been shown to have a key role because
of its ability to inhibit apoptosis of HSC via matrix metalloproteinase (MMP) inhibition. This has led
to further study of novel substrates for MMPs that might impact on HSC survival. N-Cadherin is
known to mediate cell-cell contacts in fibroblasts. In this study we demonstrate that N-Cadherin
is expressed by activated rat HSC. Furthermore, during apoptosis of HSC, the N-Cadherin is
cleaved into smaller fragments. Apoptosis of HSC may be inhibited by TIMP-1. This is associated
with reduced fragmentation of N-Cadherin. N-Cadherin may have an important role in supporting
HSC survival while N-Cadherin cleavage may play a part in promoting HSC apoptosis in recovery
from liver fibrosis.
Introduction
The activated hepatic stellate cell plays a key role in liver
fibrosis [1]. During spontaneous recovery from experi-
mental liver fibrosis loss of activated hepatic stellate cells
(HSCs) has been demonstrated to be through apoptosis
or programmed cell death [2,3]. This has highlighted con-
trol of HSC apoptosis for further investigation. During
spontaneous resolution of experimental liver fibrosis
there is a change in the balance between matrix metallo-
proteinase (MMP) activity and their endogenous inhibi-
tor TIMP-1. This change favours matrix degradation.
During resolution of fibrosis there is a great reduction in
TIMP-1 expression. Correlating with this event there is a
fall in the numbers of activated HSCs. This observation
was recently studied in depth in vitro. TIMP-1 reduced
apoptosis of culture activated HSC in a dose dependent
manner. Inhibition of HSC apoptosis by TIMP-1 has pre-
viously been shown to be due to its action of MMP inhi-
bition [4]. This has led to the further study of potential
MMPs and MMP substrates on the cell surface that might
impact on HSC survival.
N-Cadherin, which mediates cell to cell contact, is
expressed in activated HSC. It has been shown to signal
via the beta-catenin pathway. Disruption of this interac-
tion with blocking antibodies has been shown to promote
apoptosis in melanoma cells [5]. Furthermore, MMP
inhibitors including TIMPs have been demonstrated to
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promote fibroblast adhesion through stabilisation of
focal adhesion contacts and up regulation of Cadherin
function in vitro [6]. We studied the fate of N-Cadherin in
HSC during apoptosis induced by cycloheximide or glio-
toxin. We have demonstrated that activated rat HSC
express intact 135 kDa N-Cadherin and that during apop-
tosis of these cells the N-Cadherin is degraded into
smaller fragments. We have also demonstrated that TIMP-
1 is able to reduce apoptosis of activated HSC promoted
into apoptosis by cycloheximide. TIMP-1 treated rat HSC
demonstrated reduced fragmentation of N-Cadherin.
Methods
Isolation of rat HSC
Rat HSC were extracted by pronase and collagenase diges-
tion and purified by centrifugal elutriation as previously
described [7]. Extracted rat HSC were cultured on plastic
for 7–10 days in the presence of serum until activated.
Stimulation of HSC apoptosis and examination of nuclear 
morphology by acridine orange
Apoptosis of activated rat HSC was induced by exposure
to gliotoxin (1.5 micromolar) or cycloheximide (50
micromolar) in the presence of TIMP-1 (5 nanomolar) or
a mutated TIMP-1 (T2G N-TIMP-1 with no MMP inhibi-
tory activity: kind gift of Professor Hideaki Nagase). Fol-
lowing a 4 hour incubation at 37°C, nuclear morphology
was assessed by adding acridine orange to each well (final
concentration 1  g/ml) and examining the cells under
blue fluorescence. The total number of apoptotic cells
were counted and expressed as a percentage of the total
number of cells.
Quantification of HSC apoptosis by Caspase-3 activity 
assay
To validate the acridine orange assay, HSC apoptosis was
further assessed by a colorimetric assay for Caspase-3
activity (Calbiochem) following the manufacturer's
instructions.
Western blotting for N-Cadherin-Rat
HSC protein extracts from different conditions were stud-
ied by Western blotting for N-Cadherin using a mouse
monoclonal antibody to an intracellular epitope of N-
Cadherin (Clone 3B9, Zymed, California). Normalised
protein extracts (10 micrograms) were separated on 12%
SDS PAGE gels. The samples were electrotransferred onto
polyvinylidene difluoride membrane. This was blocked
using 1% non fat dry milk in TBS for 1 hour. The mem-
branes were incubated overnight with the primary anti-
body (1:100 dilution) or a non immune control IgG as a
negative control. The membranes were washed three
times in 0.1% Tween TBS (TTBS) before addition of the
secondary antibody (rabbit anti mouse horseradish per-
oxidase at 1:2000 dilution) in 0.5% non fat dry milk TBS
for 1 hour. After a further two washes with TTBS then
water, the membranes were developed using ECL (Amer-
sham Biosciences) and autoradiography according to the
manufacturer's instructions.
Results
Wild type TIMP-1 but not the inactive T2G mutant TIMP-
1 reduces apoptosis induced by cycloheximide
Both acridine orange staining and Caspase-3 activity assay
demonstrated that the wild type TIMP-1 but not the T2G
mutant TIMP-1 significantly inhibited HSC apoptosis
induced by exposure to cycloheximide for 4 hours. This
suggested that the inhibitory effect of TIMP-1 on rat HSC
apoptosis was via effects on MMP inhibition rather than
an alternative mechanism.
Cyclohexmide and gliotoxin both promote apoptosis of rat 
HSC
Exposure of rat HSC to cycloheximide or gliotoxin pro-
moted apoptosis of these cells when assessed by acridine
orange staining and was further confirmed by increased
caspase-3 activity over untreated cells.
Rat activated HSC express intact 135 kDa N-Cadherin
Western blotting of rat activated HSC protein extracts
clearly demonstrated an intact 135 kDa form of N-Cad-
herin. Furthermore, 60 and 38 kD truncated forms of N-
Cadherin were observed in protein extracts from rat acti-
vated HSC cultured in serum.
Cleavage of N-Cadherin observed during HSC apoptosis
Cleavage of N-Cadherin was demonstrated with the
appearance of a 60 kDa fragment after 3–4 hours exposure
to cycloheximide or gliotoxin. This fragmentation was
reduced by co-incubation with 5 nM recombinant TIMP-
1 but not by the non-functional T2G mutant TIMP-1.
Bioinformatic analysis of rat N-Cadherin reveals multiple 
potential MMP cleavage sites
Analysis of the known amino acid sequence of rat N-Cad-
herin reveals 19 potential cleavage sites for MMPs. This
suggests that MMPs have a role at least in part in pericel-
lular proteolysis that occurs during apoptosis of culture
activated rat HSC.
Discussion
Previous studies have shown that TIMP-1 is able to reduce
apoptosis of cultured rat and human HSC. This effect is
thought to be because of its primary function as an inhib-
itor of matrix metalloproteinases [4]. This observation has
led to the further study of which MMP and which sub-
strates might be important in mediating HSC survival or
apoptosis. This work has examined the fate of the cell sur-
face protein N-Cadherin that is known to be up regulated
during HSC activation. The activated rat HSC express
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intact 135 kDa N-Cadherin that is degraded into smaller
fragments during apoptosis induced by gliotoxin or
cycloheximide. N-Cadherin fragmentation was reduced
by exposure to TIMP-1 but not a non functional mutant
TIMP-1 (the T2G mutant TIMP-1). Protein database anal-
ysis indicated that rat and human N-Cadherin contain a
number of potential MMP cleavage sites. MMP inhibitors
have previously been demonstrated to promote survival
of fibroblasts through up regulation of N-Cadherin func-
tion [6]. MMP cleavage of N-Cadherin may be an impor-
tant mechanism promoting HSC apoptosis in recovery
from liver fibrosis.
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